Pulmonary Hypertension in Heart Failure: Pathophysiology, Pathobiology, and Emerging Clinical Perspectives

Journal of the American College of Cardiology

Volumn 69, Issue 13, 2017, Pages 1718-1734

  Guazzi, Marco ^a   Naeije, Robert ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b ERASME HOSPITAL   (Belgium)

Author keywords

cardiac output; pulmonary circulation; pulmonary wedge pressure; right ventricle

Indexed keywords

ARTERIOLE; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HEMODYNAMICS; HUMAN; LUNG ALVEOLUS; LUNG CAPILLARY; LUNG CIRCULATION; LUNG VEIN; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; BLOOD VESSEL; COMPLICATION; HEART RIGHT VENTRICLE FUNCTION; HYPERTENSION, PULMONARY; LUNG; PHYSIOLOGY; VASCULARIZATION;

BLOOD VESSELS; EXERCISE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; LUNG; PULMONARY CIRCULATION; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 85016513519     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.01.051     Document Type: Review

References (102)

1. 1 Parker, F., Weiss, S., The nature and significance of the structural changes in the lungs in mitral stenosis. Am J Pathol 12 (1936), 573–598.
2. 2 Guazzi, M., Borlaug, B.A., Pulmonary hypertension due to left heart disease. Circulation 126 (2012), 975–990.
3. 3 Harris, P., Heath, D., The Human Pulmonary Circulation: Its Form and Function in Health and Disease. 1962, E. & S. Livingstone, Edinburgh, United Kingdom.
4. 4 Tandon, H.D., Kasturi, J., Pulmonary vascular changes associated with isolated mitral stenosis in India. Br Heart J 37 (1975), 26–36.
5. 5 Cournand, A., Bloomfield, R.A., Lauson, H.D., Double lumen catheter for intravenous and intracardiac blood sampling and pressure recording. Proc Soc Exp Biol Med 60 (1945), 73–75.
6. 6 Wood, P., Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J 20 (1958), 557–570.
7. 7 Kovacs, G., Berghold, A., Scheidl, S., et al. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34 (2009), 888–894.
8. 8 Connolly, D.C., Kirklin, J.W., Wood, E.H., The relationship between pulmonary artery wedge pressure and left atrial pressure in man. Circ Res 2 (1954), 434–440.
9. 9 Harvey, R.M., Enson, Y., Ferrer, M.I., A reconsideration of the origins of pulmonary hypertension. Chest 59 (1971), 82–94.
10. 10 Tedford, R.J., Hassoun, P.M., Mathai, S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 125 (2012), 289–297.
11. 11 Naeije, R., Vachiery, J.L., Yerly, P., et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 41 (2013), 217–223.
12. 12 Reeves, J.T., Linehan, J.H., Stenmark, K.R., Distensibility of the normal human lung circulation during exercise. Am J Physiol Lung Cell Mol Physiol 288 (2005), L419–L425.
13. 13 Linehan, J.H., Haworth, S.T., Nelin, L.D., et al. A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J App Physiol (1985) 73 (1992), 987–994.
14. 14 Naeije, R., Vanderpool, R., Dhakal, B.P., et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 187 (2013), 576–583.
15. 15 Lau, E.M., Chemla, D., Godinas, L., et al. Loss of vascular distensibility during exercise is an early hemodynamic marker of pulmonary vascular disease. Chest 149 (2016), 353–361.
16. 16 Malhotra, R., Dhakal, B.P., Eisman, A.S., et al. Pulmonary vascular distensibility predicts pulmonary hypertension severity, exercise capacity, and survival in heart failure. Circ Heart Fail, 9, 2016, e003011.
17. 17 Naeije, R., Lipski, A., Abramowicz, M., et al. Nature of pulmonary hypertension in congestive heart failure. Effects of cardiac transplantation. Am J Respir Crit Care Med 149 (1994), 881–887.
18. 18 Dalen, J.E., Dexter, L., Ockene, I.S., et al. Precapillary pulmonary hypertension; its relationship to pulmonary venous hypertension. Trans Am Clin Climatol Assoc 86 (1975), 207–218.
19. 19 Tumminello, G., Lancellotti, P., Lempereur, M., et al. Determinants of pulmonary artery hypertension at rest and during exercise in patients with heart failure. Eur Heart J 28 (2007), 569–574.
20. 20 Barbieri, A., Bursi, F., Grigioni, F., et al., for the Mitral Regurgitation International Database (MIDA) Investigators. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32 (2011), 751–759.
21. 21 Alexopoulos, D., Lazzam, C., Borrico, S., et al. Isolated chronic mitral regurgitation with preserved systolic left ventricular function and severe pulmonary hypertension. J Am Coll Cardiol 14 (1989), 319–322.
22. 22 Guazzi, M., Villani, S., Generati, G., et al. Right ventricular contractile reserve and pulmonary circulation uncoupling during exercise challenge in heart failure: pathophysiology and clinical phenotypes. J Am Coll Cardiol HF 4 (2016), 625–635.
23. 23 West, J.B., Mathieu-Costello, O., Vulnerability of pulmonary capillaries in heart disease. Circulation 92 (1995), 622–631.
24. 24 Guazzi, M., Arena, R., Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 7 (2010), 648–659.
25. 25 Conforti, E., Fenoglio, C., Bernocchi, G., et al. Morpho-functional analysis of lung tissue in mild interstitial edema. Am J Physiol Lung Cell Mol Physiol 282 (2002), L766–L774.
26. 26 De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., et al. Plasma surfactant protein-b: a novel biomarker in chronic heart failure. Circulation 110 (2004), 1091–1096.
27. 27 Chen, D.D., Dong, Y.G., Yuan, H., et al. Endothelin 1 activation of endothelin A receptor/NADPH oxidase pathway and diminished antioxidants critically contribute to endothelial progenitor cell reduction and dysfunction in salt-sensitive hypertension. Hypertension 59 (2012), 1037–1043.
28. 28 Kay, J.M., Edwards, F.R., Ultrastructure of the alveolar capillary wall in mitral stenosis. J Pathol, 109, 1973, Pvi.
29. 29 Lee, Y.S., Electron microscopic studies on the alveolar-capillary barrier in the patients of chronic pulmonary edema. Jpn Circ J 43 (1979), 945–954.
30. 30 Drake, R.E., Doursout, M.F., Pulmonary edema and elevated left atrial pressure: four hours and beyond. News Physiol Sci 17 (2002), 223–226.
31. 31 Kapanci, Y., Burgan, S., Pietra, G.G., et al. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am J Pathol 136 (1990), 881–889.
32. 32 Kim, K.K., Kugler, M.C., Wolters, P.J., et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103 (2006), 13180–13185.
33. 33 Razani, B., Engelman, J.A., Wang, X.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276 (2001), 38121–38138.
34. 34 Jasmin, J.F., Mercier, I., Hnasko, R., et al. Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res 63 (2004), 747–755.
35. 35 Guazzi, M., Phillips, S.A., Arena, R., et al. Endothelial dysfunction and lung capillary injury in cardiovascular diseases. Prog Cardiovasc Dis 57 (2015), 454–462.
36. 36 Bland, R.D., Lung epithelial ion transport and fluid movement during the perinatal period. Am J Physiol 259 (1990), L30–L37.
37. 37 Park, J.E., Lyon, A.R., Shao, D., et al. Pulmonary venous hypertension and mechanical strain stimulate monocyte chemoattractant protein-1 release and structural remodelling of the lung in human and rodent chronic heart failure models. Thorax 69 (2014), 1120–1127.
38. 38 Assad, T.R., Hemnes, A.R., Larkin, E.K., et al. Clinical and biological insights into combined post- and pre-capillary pulmonary hypertension. J Am Coll Cardiol 68 (2016), 2525–2536.
39. 39 Cooper, C.J., Jevnikar, F.W., Walsh, T., et al. The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure. Am J Cardiol 82 (1998), 609–614.
40. 40 Ooi, H., Colucci, W.S., Givertz, M.M., Endothelin mediates increased pulmonary vascular tone in patients with heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan. Circulation 106 (2002), 1618–1621.
41. 41 Stamler, J.S., Loh, E., Roddy, M.A., et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89 (1994), 2035–2040.
42. 42 Hsia, C.C., Recruitment of lung diffusing capacity: update of concept and application. Chest 122 (2002), 1774–1783.
43. 43 Porter, T.R., Taylor, D.O., Cycan, A., et al. Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. J Am Coll Cardiol 22 (1993), 1418–1424.
44. 44 Hunt, J.M., Bethea, B., Liu, X., et al. Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. Am J Physiol Lung Cell Mol Physiol 305 (2013), L725–L736.
45. 45 Matalon, S., O'Brodovich, H., Sodium channels in alveolar epithelial cells: molecular characterization, biophysical properties, and physiological significance. Annu Rev Physiol 61 (1999), 627–661.
46. 46 Azzam, Z.S., Dumasius, V., Saldias, F.J., et al. Na,K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation 105 (2002), 497–501.
47. 47 Guazzi, M., Alveolar gas diffusion abnormalities in heart failure. J Card Fail 14 (2008), 695–702.
48. 48 Guazzi, M., Pontone, G., Brambilla, R., et al. Alveolar–capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 23 (2002), 467–476.
49. 49 Kitzman, D.W., Guazzi, M., Impaired alveolar capillary membrane diffusion: a recently recognized contributor to exertional dyspnea in heart failure with preserved ejection fraction. J Am Coll Cardiol HF 4 (2016), 499–501.
50. 50 Galiè, N., Humbert, M., Vachiery, J.L., et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37 (2015), 67–119.
51. 51 Stevens, P.M., Assessment of acute respiratory failure: cardiac versus pulmonary causes. Chest 67 (1975), 1–2.
52. 52 Gerges, C., Gerges, M., Lang, M.B., et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest 143 (2013), 758–766.
53. 53 Vachiéry, J.L., Adir, Y., Barberà, J.A., et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 62 (2013), D100–D108.
54. 54 Tampakakis, E., Leary, P.J., Selby, V.N., et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. J Am Coll Cardiol HF 3 (2015), 9–16.
55. 55 Gerges, C., Gerges, M., Lang, I.M., Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient. J Am Coll Cardio HF 3 (2015), 424–425.
56. 56 Ghio, S., Gavazzi, A., Campana, C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37 (2001), 183–188.
57. 57 Naeije, R., Measurement to predict survival: the case of diastolic pulmonary gradient. J Am Coll Cardio HF, 3, 2015, 425.
58. 58 Gerges, M., Gerges, C., Lang, I.M., How to define pulmonary hypertension due to left heart disease. Eur Respir J 48 (2016), 553–555.
59. 59 Gerges, M., Gerges, C., Pistritto, A.M., et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 192 (2015), 1234–1246.
60. 60 Guazzi, M., Bandera, F., Pelissero, G., et al. Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis. Am J Physiol Heart Circ Physiol 305 (2013), H1373–H1381.
61. 61 Borlaug, B.A., Nishimura, R.A., Sorajja, P., et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 3 (2010), 588–595.
62. 62 Fujimoto, N., Borlaug, B.A., Lewis, G.D., et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation 127 (2013), 55–62.
63. 63 Maor, E., Grossman, Y., Balmor, R.G., et al. Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension. Eur J Heart Fail 17 (2015), 151–158.
64. 64 Robbins, I.M., Hemnes, A.R., Pugh, M.E., et al. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail 7 (2014), 116–122.
65. 65 Lewis, G.D., Bossone, E., Naeije, R., et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 128 (2013), 1470–1479.
66. 66 Wolsk E, Bakkestrøm R, Thomsen JH, et al. The influence of age on hemodynamic parameters during rest and exercise in healthy individuals. J Am Coll Cardiol HF 2016 Dec 21 [E-pub ahead of print].
67. 67 Oliveira, R.K., Agarwal, M., Tracy, J.A., et al. Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics. Eur Respir J 47 (2016), 1179–1188.
68. 68 Kovacs, G., Avian, A., Olschewski, H., Proposed new definition of exercise pulmonary hypertension decreases false-positive cases. Eur Respir J 47 (2016), 1270–1273.
69. 69 Kovacs, G., Avian, A., Pienn, M., et al. Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 190 (2014), 252–257.
70. 70 D'Alto, M., Romeo, E., Argiento, P., et al. Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension. Chest 151 (2017), 119–126.
71. 71 Andersen, M.J., Olson, T.P., Melenovsky, V., et al. Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail 8 (2015), 41–48.
72. 72 Guazzi, M., Letter by Guazzi regarding article, “Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure.”. Circ Heart Fail, 8, 2015, 410.
73. 73 Rosenkranz, S., Gibbs, J.S., Wachter, R., et al. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 37 (2016), 942–954.
74. 74 Bernheim, P., De l'asystolie veineuse dans l'hypertrophie du coeur gauche par stenose concomitante du ventricule droit. Rev Med 39 (1910), 785–794.
75. 75 Henderson, Y., Prince, A.L., The relative systolic discharges of the right and left ventricles and their bearing on pulmonary congestion and depletion. Heart 5 (1914), 217–226.
76. 76 Yamaguchi, S., Harasawa, H., Li, K.S., et al. Comparative significance in systolic ventricular interaction. Cardiovasc Res 25 (1991), 774–783.
77. 77 Yaku, H., Slinker, B.K., Bell, S.P., et al. Effects of free wall ischemia and bundle branch block on systolic ventricular interaction in dog hearts. Am J Physiol 266 (1994), H1087–H1094.
78. 78 Santamore, W.P., Dell'Italia, L.J., Ventricular interdependence: Significant left ventricular contributions to right ventricular systolic function. Progress Cardiovasc Dis 40 (1998), 289–308.
79. 79 Vonk-Noordegraaf, A., Haddad, F., Chin, K.M., et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62 (2013), D22–D33.
80. 80 van de Veerdonk, M.C., Marcus, J.T., Westerhof, N., et al. Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension. Chest 147 (2015), 1063–1071.
81. 81 Kuehne, T., Yilmaz, S., Steendijk, P., et al. Magnetic resonance imaging analysis of right ventricular pressure-volume loops: in vivo validation and clinical application in patients with pulmonary hypertension. Circulation 110 (2004), 2010–2016.
82. 82 Tedford, R.J., Mudd, J.O., Girgis, R.E., et al. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension. Circ Heart Fail 6 (2013), 953–963.
83. 83 McCabe, C., White, P.A., Hoole, S.P., et al. Right ventricular dysfunction in chronic thromboembolic obstruction of the pulmonary artery: a pressure-volume study using the conductance catheter. J Appl Physiol (1985) 116 (2014), 355–363.
84. 84 Spruijt, O.A., de Man, F.S., Groepenhoff, H., et al. The effects of exercise on right ventricular contractility and right ventricular-arterial coupling in pulmonary hypertension. Am J Respir Crit Care Med 191 (2015), 1050–1057.
85. 85 Brimioulle, S., Wauthy, P., Ewalenko, P., et al. Single-beat estimation of right ventricular end-systolic pressure-volume relationship. Am J Physiol Heart Circ Physiol 284 (2003), H1625–H1630.
86. 86 Rain, S., Handoko, M.L., Trip, P., et al. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension. Circulation 128 (2013), 2016–2025.
87. 87 Naeije, R., Assessment of right ventricular function in pulmonary hypertension. Curr Hypertens Rep, 17, 2015, 35.
88. 88 Pagnamenta, A., Dewachter, C., McEntee, K., et al. Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure. J Appl Physiol (1985) 109 (2010), 1080–1085.
89. 89 Sanz, J., García-Alvarez, A., Fernández-Friera, L., et al. Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study. Heart 98 (2012), 238–243.
90. 90 Vanderpool, R.R., Pinsky, M.R., Naeije, R., et al. RV-pulmonary arterial coupling predicts outcome in patients referred for pulmonary hypertension. Heart 101 (2015), 37–43.
91. 91 Vanderpool, R.R., Rischard, F., Naeije, R., et al. Simple functional imaging of the right ventricle in pulmonary hypertension: can right ventricular ejection fraction be improved?. Int J Cardiol 223 (2016), 93–94.
92. 92 Guazzi M, Labate V, Beussink-Nelson L, et al. Right ventricular contractile function and its coupling to the pulmonary circulation stratify clinical phenotypes and outcomes in heart failure with preserved ejection fraction. J Am Coll Cardiol Img. [E-pub ahead of print].
93. 93 Ghio S, Guazzi M, Scardovi AB, et al., for All Investigators. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction. Eur J Heart Fail 2016 Nov 17 [E-pub ahead of print].
94. 94 Borlaug, B.A., Kane, G.C., Melenovsky, V., et al. Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. Eur Heart J 37 (2016), 3293–3302.
95. 95 Dupuis, J., Guazzi, M., Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases. Can J Cardiol 31 (2015), 416–429.
96. 96 Guazzi, M., Vicenzi, M., Arena, R., et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 124 (2011), 164–174.
97. 97 Hoendermis, E.S., Liu, L.C., Hummel, Y.M., et al. Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial. Eur Heart J 36 (2015), 2565–2573.
98. 98 Bonderman, D., Pretsch, I., Steringer-Mascherbauer, R., et al. Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study. Chest 146 (2014), 1274–1285.
99. 99 Bonderman, D., Ghio, S., Felix, S.B., et al., for the Left Ventricular Systolic Dysfunction Associated With Pulmonary Hypertension Riociguat Trial (LEPHT) Study Group. Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study. Circulation 128 (2013), 502–511.
100. 100 Borlaug, B.A., Koepp, K.E., Melenovsky, V., Sodium nitrite improves exercise hemodynamics and ventricular performance in heart failure with preserved ejection fraction. J Am Coll Cardiol 66 (2015), 1672–1682.
101. 101 Simon, M.A., Vanderpool, R.R., Nouraie, M., et al. Acute hemodynamic effects of inhaled sodium nitrite in pulmonary hypertension associated with heart failure with preserved ejection fraction. JCI Insight, 1, 2016, e89620.
102. 102 Opitz, C.F., Hoeper, M.M., Gibbs, J.S., et al. Pre-capillary, combined, and post-capillary pulmonary hypertension: a pathophysiological continuum. J Am Coll Cardiol 68 (2016), 368–378.